BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 29029237)

  • 1. CPAP Does Not Reduce Inflammatory Biomarkers in Patients With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea: A Randomized Controlled Trial.
    Thunström E; Glantz H; Yucel-Lindberg T; Lindberg K; Saygin M; Peker Y
    Sleep; 2017 Nov; 40(11):. PubMed ID: 29029237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Positive Airway Pressure Treatment and Depression in Adults with Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea. A Secondary Analysis of the RICCADSA Trial.
    Balcan B; Thunström E; Strollo PJ; Peker Y
    Ann Am Thorac Soc; 2019 Jan; 16(1):62-70. PubMed ID: 30130421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial.
    Peker Y; Glantz H; Eulenburg C; Wegscheider K; Herlitz J; Thunström E
    Am J Respir Crit Care Med; 2016 Sep; 194(5):613-20. PubMed ID: 26914592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPAP and Health-Related Quality of Life in Adults With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea in the RICCADSA Trial.
    Wallström S; Balcan B; Thunström E; Wolf A; Peker Y
    J Clin Sleep Med; 2019 Sep; 15(9):1311-1320. PubMed ID: 31538602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of continuous positive airway pressure therapy in coronary artery disease patients with nonsleepy obstructive sleep apnea.
    Luyster FS; Strollo PJ; Thunström E; Peker Y
    Clin Cardiol; 2017 Dec; 40(12):1297-1302. PubMed ID: 29243273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous positive airway pressure treatment and anxiety in adults with coronary artery disease and nonsleepy obstructive sleep apnea in the RICCADSA trial.
    Celik Y; Thunström E; Strollo PJ; Peker Y
    Sleep Med; 2021 Jan; 77():96-103. PubMed ID: 33341644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased inflammatory activity in nonobese patients with coronary artery disease and obstructive sleep apnea.
    Thunström E; Glantz H; Fu M; Yucel-Lindberg T; Petzold M; Lindberg K; Peker Y
    Sleep; 2015 Mar; 38(3):463-71. PubMed ID: 25325463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Continuous Positive Airway Pressure on Lipidaemia and High-sensitivity C-reactive Protein Levels in Non-obese Patients with Coronary Artery Disease and Obstructive Sleep Apnoea.
    Huang Z; Liu Z; Zhao Z; Zhao Q; Luo Q; Tang Y
    Heart Lung Circ; 2016 Jun; 25(6):576-83. PubMed ID: 26804247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Outcomes in Adults with Coronary Artery Disease and Obstructive Sleep Apnea with versus without Excessive Daytime Sleepiness in the RICCADSA Cinical Trial.
    Eulenburg C; Celik Y; Redline S; Thunström E; Glantz H; Strollo PJ; Peker Y
    Ann Am Thorac Soc; 2023 Jul; 20(7):1048-1056. PubMed ID: 36800433
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of CPAP on diastolic function in coronary artery disease patients with nonsleepy obstructive sleep apnea: A randomized controlled trial.
    Glantz H; Johansson MC; Thunström E; Guron CW; Uzel H; Saygin M; Herlitz J; Peker Y
    Int J Cardiol; 2017 Aug; 241():12-18. PubMed ID: 28408103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of CPAP treatment on leptin and adiponectin in adults with coronary artery disease and nonsleepy obstructive sleep apnoea in the RICCADSA trial.
    Balcan B; Thunström E; Yucel-Lindberg T; Lindberg K; Ay P; Peker Y
    Sleep Med; 2020 Mar; 67():7-14. PubMed ID: 31884309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive sleep apnea and self-reported functional impairment in revascularized patients with coronary artery disease in the RICCADSA trial.
    Baniak LM; Chasens ER; Luyster FS; Strollo PJ; Thunström E; Peker Y
    Sleep Breath; 2018 Dec; 22(4):1169-1177. PubMed ID: 30324547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of Myocardial Ischemia in Patients With Coronary Artery Disease and Obstructive Sleep Apnea: Effect of Continuous Positive Airway Pressure Therapy.
    Valo M; Wons A; Moeller A; Teupe C
    Clin Cardiol; 2015 Aug; 38(8):462-8. PubMed ID: 26175232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between inflammation and cognitive function and effects of continuous positive airway pressure treatment in obstructive sleep apnea hypopnea syndrome].
    Sun L; Chen R; Wang J; Zhang Y; Li J; Peng W; Liu C
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(44):3483-7. PubMed ID: 25622738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial.
    Barbé F; Durán-Cantolla J; Sánchez-de-la-Torre M; Martínez-Alonso M; Carmona C; Barceló A; Chiner E; Masa JF; Gonzalez M; Marín JM; Garcia-Rio F; Diaz de Atauri J; Terán J; Mayos M; de la Peña M; Monasterio C; del Campo F; Montserrat JM;
    JAMA; 2012 May; 307(20):2161-8. PubMed ID: 22618923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of continuous positive airway pressure on inflammatory, antioxidant, and depression biomarkers in women with obstructive sleep apnea: a randomized controlled trial.
    Campos-Rodriguez F; Asensio-Cruz MI; Cordero-Guevara J; Jurado-Gamez B; Carmona-Bernal C; Gonzalez-Martinez M; Troncoso MF; Sanchez-Lopez V; Arellano-Orden E; Garcia-Sanchez MI; Martinez-Garcia MA;
    Sleep; 2019 Oct; 42(10):. PubMed ID: 31314107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPAP Intervention as an Add-On Treatment to Lipid-Lowering Medication in Coronary Artery Disease Patients with Obstructive Sleep Apnea in the RICCADSA Trial.
    Celik Y; Balcan B; Peker Y
    J Clin Med; 2022 Jan; 11(1):. PubMed ID: 35012012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological Traits and Adherence to Sleep Apnea Therapy in Individuals with Coronary Artery Disease.
    Zinchuk AV; Chu JH; Liang J; Celik Y; Op de Beeck S; Redeker NS; Wellman A; Yaggi HK; Peker Y; Sands SA
    Am J Respir Crit Care Med; 2021 Sep; 204(6):703-712. PubMed ID: 34156917
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness.
    Azarbarzin A; Zinchuk A; Wellman A; Labarca G; Vena D; Gell L; Messineo L; White DP; Gottlieb DJ; Redline S; Peker Y; Sands SA
    Am J Respir Crit Care Med; 2022 Sep; 206(6):767-774. PubMed ID: 35579605
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex-Specific Differential Responses of Circulating Biomarkers in Obstructive Sleep Apnea Treatment. A
    May AM; Wang L; Strohl KP; Walia H; Hazen SL; Mehra R
    Ann Am Thorac Soc; 2020 May; 17(5):605-613. PubMed ID: 31860326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.